Novozymes Overview

  • Founded
  • 1920
Founded
  • Status
  • Public
  • Employees
  • 6,369
Employees
  • Stock Symbol
  • NZYM B
Stock Symbol
  • Investments
  • 34
  • Share Price
  • $74.69
  • (As of Thursday Closing)

Novozymes General Information

Description

Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
CSE
Primary Office
  • Krogshoejvej 36
  • 2880 Bagsvaerd
  • Denmark
+45 44 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novozymes Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$74.69 $75.96 $54.47 - $81.40 $20.7B 277M 331K $1.83

Novozymes Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 18,939,290 16,047,914 13,745,162 13,207,123
Revenue 2,339,622 2,142,095 2,155,171 2,277,854
EBITDA 861,433 754,136 762,571 783,556
Net Income 510,080 431,874 472,896 510,657
Total Assets 3,405,120 3,389,993 3,063,954 3,017,384
Total Debt 83,154 624,116 508,385 499,093
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Novozymes Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novozymes‘s full profile, request access.

Request a free trial

Novozymes Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, pri
Biotechnology
Bagsvaerd, Denmark
6,369 As of 2021
00000000

000000

or incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation u
0000000000000
Emeryville, CA
000 As of 0000
00.000
000000000 00.000

00000000

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
0000000000000
Mumbai, India
000 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novozymes Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amyris Formerly VC-backed Emeryville, CA 000 00.000 000000000 00.000
00000000 000000 00 Formerly PE-Backed Mumbai, India 000 000.00 00000000000 000.00
0000000 Formerly VC-backed Redwood City, CA 000 00000 000000 - 000 00000
0000000 Private Debt Financed Nicholasville, KY 0000 00000 000000000 00000
00000000 Venture Capital-Backed Berkeley, CA 00 0000 00000000000 0000
You’re viewing 5 of 7 competitors. Get the full list »

Novozymes Patents

Novozymes Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210284934-A1 Detergent compositions and uses thereof Pending 11-Mar-2020 00000000000
US-20210077547-A1 Spore-based probiotic composition for modulation of microbiome in humans Pending 12-Sep-2019 00000000
EP-3744838-A1 Lipolytic polymer particles for esterification and interesterification Pending 29-May-2019 0000000000 00
AU-2020252635-A1 Redox enzymes in animal feed compositions Pending 05-Apr-2019 0000000000
AU-2020249310-A1 Use of muramic acid as a biomarker for gastrointestinal peptidoglycan hydrolysis Pending 22-Mar-2019 C12Y302/01017

Novozymes Executive Team (47)

Name Title Board Seat Contact Info
Ester Baiget Chief Executive Officer & President
Ten Melnik President, Novozymes Biologicals
Lars Green Chief Financial Officer & Executive Vice President
Naja Wivel Investor Relations Coordinator
Jens-Ulrik Rype Ph.D Recovery Scientist
You’re viewing 5 of 47 executive team members. Get the full list »

Novozymes Board Members (12)

Name Representing Role Since
000000 0000000 Novozymes Board Member 000 0000
0000 0000 Novozymes Board Member & Vice Chairman 000 0000
00000 000000000 Novozymes Board Member 000 0000
0ø0000 000000000 Novozymes Chairman 000 0000
00000 00000 Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Novozymes Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novozymes Investments & Acquisitions (34)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 11-Mar-2021 0000000000 Biotechnology 00000 000
00000 (0&0 00 11-Mar-2021 0000000000 Biotechnology 00000 000
0000000000 00 07-Jan-2021 0000000000 00000 Pharmaceuticals 00000 000
0000000000000 25-Jun-2020 0000000000 00000 Drug Discovery
Plant Response 13-Dec-2018 Later Stage VC 00.000 Agricultural Chemicals
You’re viewing 5 of 34 investments and acquisitions. Get the full list »

Novozymes Subsidiaries (8)

Company Name Industry Location Founded
Biota Biotechnology San Diego, CA 2014
0000000000 0000 Pharmaceuticals Glenview, IL 0000
0000000 000 00000- Biotechnology Fayetteville, AR 0000
0000000000000 Biotechnology Berlin, Germany 0000
0000000000000000 0 Drug Discovery Cork, Ireland 0000
You’re viewing 5 of 8 subsidiaries. Get the full list »

Novozymes Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 0000000000 05-Nov-2012 00000 00000 00 00000 Completed
  • 000000000
Roots Sustainable Agricultural Technologies 01-Jul-2001 Merger/Acquisition Completed
To view Novozymes’s complete exits history, request access »